Articles published by BostonGene

BostonGene Announces Publication in Blood

December 20, 2023

Sarcoma Oncology Center Leverages BostonGene’s AI-Driven Molecular and Immune Profiling Platform to Identify Novel Treatment Options for Patients with Advanced Cancers

December 12, 2023

From BostonGene

Via Business Wire

BostonGene Announces Ten Presentations at the 65th American Society of Hematology Annual Meeting & Exposition

December 07, 2023

From BostonGene

Via Business Wire

BostonGene to Present at the 2023 San Antonio Breast Cancer Symposium

December 06, 2023

From BostonGene

Via Business Wire

BostonGene Wins Fierce Life Sciences Innovation Award for AI-Driven Clinical Trials Matching Algorithm

November 29, 2023

From BostonGene

Via Business Wire

BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2023 Annual Meeting

November 13, 2023

From BostonGene

Via Business Wire

BostonGene and Weill Cornell Medicine to Showcase Poster Presentations on Transcriptome-based Tumor Microenvironment Classification for Advancement of Personalized Cancer Therapeutics at the 20th International Cancer Genome Consortium Scientific...

November 07, 2023

From BostonGene

Via Business Wire

LegoChem Biosciences Selects BostonGene as Genomic Partner for First-in-Human Clinical Trial

November 07, 2023

From BostonGene

Via Business Wire

BostonGene Announces Poster Presentation at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting

October 31, 2023

From BostonGene

Via Business Wire

BostonGene and FibroFighters Collaborate to Revolutionize Clinical Care for Patients with Fibrolamellar Carcinomas

October 25, 2023

From BostonGene

Via Business Wire

BostonGene and Exigent Research Announce Clinical Trial Agreement to Bring Molecular Testing to Community Settings

October 24, 2023

From BostonGene

Via Business Wire

BostonGene Announces Three Abstract Acceptances at ESMO Congress 2023

October 17, 2023

From BostonGene

Via Business Wire

BostonGene Announces Master Agreement With Johns Hopkins University School of Medicine

October 03, 2023

From BostonGene

Via Business Wire

BostonGene to Present Unique AI-Driven Bioinformatic Solutions at the Festival of Genomics & Biodata

October 02, 2023

From BostonGene

Via Business Wire

BostonGene to Showcase Integrated Approach to Precision Medicine at the 82nd Annual Meeting of the Japanese Cancer Association

September 20, 2023

From BostonGene

Via Business Wire

BostonGene, NEC and JIP Form Joint Venture in Japan

August 24, 2023

From BostonGene

Via Business Wire

BostonGene to Present Approach for Patient Stratification and Selection of IO Clinical Trials Using Molecular and Immune Profiling at the 11th Annual Immuno-Oncology Summit

August 03, 2023

From BostonGene

Via Business Wire

BostonGene Announces the Launch of its CLIA-certified and CAP-accredited Liquid Biopsy, Immunoprofiling and Spatial Proteomics Solutions

June 02, 2023

From BostonGene

Via Business Wire

BostonGene Announces Six Abstract Acceptances at the 2023 American Society of Clinical Oncology Annual Meeting

June 01, 2023

From BostonGene

Via Business Wire

BostonGene and Sylvester Comprehensive Cancer Center at the University of Miami Announce Collaboration

May 23, 2023

From BostonGene

Via Business Wire

BostonGene Announces Acceptance of Eight Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2023

April 11, 2023

From BostonGene

Via Business Wire

BostonGene and Little Warrior Foundation Collaborate to Bring Novel Liquid Biopsy Solutions into Clinical Practice

March 22, 2023

From BostonGene

Via Business Wire

BostonGene to Present at the 2022 San Antonio Breast Cancer Symposium

November 29, 2022

From BostonGene

Via Business Wire

BostonGene Announces Publication in Cell Reports Revealing Spatial Heterogeneity in the Tumor Microenvironment of Multiregional Clear Cell Renal Cell Carcinoma Biopsies

October 04, 2022

From BostonGene

Via Business Wire

BostonGene Showcases Lifesaving Cancer Diagnostic and Treatment Recommendation Test at The 81st Annual Meeting of the Japanese Cancer Association

September 21, 2022

From BostonGene

Via Business Wire

BostonGene Announces Publication in Cancer Cell Revealing the Development of a Machine Learning Cellular Deconvolution Algorithm that Accurately Reconstructs the Tumor Microenvironment and Supports Oncology Clinical Decision-making

August 09, 2022

From BostonGene

Via Business Wire

BostonGene to Present at the 2022 American Society of Clinical Oncology Annual Meeting

June 03, 2022

From BostonGene

Via Business Wire

BostonGene Announces Integration With NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

May 10, 2022

From BostonGene

Via Business Wire

BostonGene Announces Acceptance of Six Abstracts to be Presented at the American Association for Cancer Research Annual Meeting 2022

April 07, 2022

From BostonGene

Via Business Wire

BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status

April 06, 2022

From BostonGene

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.